BENSALEM, Pa.--(BUSINESS WIRE)--
Law Offices of Howard G. Smith announces an investigation on behalf of Diplomat Pharmacy, Inc. investors (“Diplomat” or the “Company”) (NYSE: DPLO) concerning the Company and its officers’ possible violations of federal securities laws.
On February 22, 2019, Diplomat disclosed the postponement of the release of its Q4 and full-year 2018 earnings as it worked to finalize the amount of an impairment charge, which was “expected to be equal to a significant portion of the PBM’s Goodwill and Definite-lived intangible assets, which total approximately $630 million as of December 31, 2018, prior to impairment charges.” On this news, shares of fell $7.59 or 56%, to close at $5.87 on February 22, 2019, thereby injuring investors.
If you purchased Diplomat securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.